back to homepage


Sanofi Stock Update: Mergers, Licensure Agreements To Boost Company Revenue in 2016

Given a strong drug pipeline and company financials, analysts expect Sanofi stock to do well in 2016. Sanofi ADR (NYSE:SNY) shares closed down 1.68% on December 31, 2015. The stock’s

Read More

Midatech Completes Acquisition of Zuplenz from Galena Biopharma

Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology and other therapeutic areas, announced the successful completion of its previously announced acquisition of Zuplenz

Read More

Food, Drug & Device Law Alert – FDA Issues Draft Guidance on Voluntary Labeling of GMO Foods

The Food and Drug Administration (FDA) recently issued a draft guidance for manufacturers of human and animal food who want the labels of their products to indicate whether (or not)

Read More